Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ASSEMBLY BIOSCIENCES, INC.v244957_ex99-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  January 9, 2012

 
VENTRUS BIOSCIENCES, INC.
 
 
(Exact name of registrant as specified in its charter)
 
 
Delaware
001-35005
20-8729264
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer ID Number)
     
99 Hudson Street, 5th Floor, New York, New York
10013
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code
(646) 706-5208
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act   (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 8.01.  Other Events.
 
Attached hereto as Exhibit 99.1 is a PowerPoint presentation that Ventrus Biosciences, Inc. will present to investors and at various industry events and which is incorporated herein by reference.
 
Item 9.01. Financial Statements and Exhibits.
 
(d)           Exhibits

Exhibit No.
Description
   
99.1
Slide presentation of January 2012.
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  VENTRUS BIOSCIENCES, INC.  
     
     
Date:  January 9, 2012
/s/ David J. Barrett
 
 
David J. Barrett, Chief Financial Officer